Published in Cancer Res on December 15, 1996
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J (1998) 9.36
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci U S A (2002) 2.69
Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal (2009) 2.33
Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest (2003) 2.19
Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med (1999) 1.84
The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol (2010) 1.18
Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid. Mol Cell Biol (1998) 1.06
Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res (1997) 1.05
Peroxiredoxins, gerontogenes linking aging to genome instability and cancer. Genes Dev (2012) 1.04
Distinction of thioredoxin transnitrosylation and denitrosylation target proteins by the ICAT quantitative approach. J Proteomics (2011) 0.98
Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. Antioxid Redox Signal (2011) 0.97
Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation. Cancers (Basel) (2010) 0.97
Thioredoxin in cancer--role of histone deacetylase inhibitors. Semin Cancer Biol (2006) 0.93
Hydrogen peroxide - production, fate and role in redox signaling of tumor cells. Cell Commun Signal (2015) 0.91
Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol (2006) 0.90
Thioredoxin-1 redox signaling regulates cell survival in response to hyperoxia. Free Radic Biol Med (2014) 0.86
Reactive oxygen species-independent oxidation of thioredoxin in hypoxia: inactivation of ribonucleotide reductase and redox-mediated checkpoint control. J Biol Chem (2009) 0.84
Genomic organisation and alternative splicing of mouse and human thioredoxin reductase 1 genes. BMC Genomics (2001) 0.82
A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers. Invest New Drugs (2012) 0.81
Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells. J Biol Chem (2016) 0.81
Aging is an organ-specific process: changes in homeostasis of iron and redox proteins in the rat. Age (Dordr) (2011) 0.80
MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion. Oncol Rep (2012) 0.80
The thioredoxin system in breast cancer cell invasion and migration. Redox Biol (2015) 0.79
The tert-butylhydroquinone-mediated activation of the human thioredoxin gene reveals a novel promoter structure. Biochem J (2006) 0.78
Thioredoxin-deficient mice, a novel phenotype sensitive to ambient air and hypersensitive to hyperoxia-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2014) 0.77
Role of in vivo vascular redox in resistance arteries. Hypertension (2014) 0.76
Two-layer modular analysis of gene and protein networks in breast cancer. BMC Syst Biol (2014) 0.76
The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer. Onco Targets Ther (2016) 0.75
Monitoring thioredoxin redox with a genetically encoded red fluorescent biosensor. Nat Chem Biol (2017) 0.75
The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk. Antioxidants (Basel) (2017) 0.75
Changes in the epithelium of the cervix uteri. A study by the panel of pathologists engaged in the survey of carcinoma in situ carried out by the Royal College of Obstetricians and Gynaecologists. J Obstet Gynaecol Br Commonw (1966) 5.13
The histology and cytology of changes in the epithelium of the cervix uteri. J Clin Pathol (1969) 4.25
Thioredoxin reductase. Biochem J (2000) 3.47
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol (1989) 2.89
The prevalence of peripheral arterial disease in a defined population. Circulation (1985) 2.88
RNA chain growth rates in Escherichia coli. J Mol Biol (1969) 2.87
Childhood lead poisoning in Massachusetts communities: its association with sociodemographic and housing characteristics. Am J Public Health (1995) 2.39
Nucleotide sequence of 4.5 S ribonucleic acid of Novikoff hepatoma cell nuclei. J Biol Chem (1972) 2.30
New duplication-generating inversions in Neurospora. Can J Genet Cytol (1969) 2.30
A pericentric inversion in Neurospora, with unstable duplication progeny. Genetics (1967) 2.25
Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia (1999) 2.24
Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum (1998) 2.19
Spontaneous calcium release from inositol trisphosphate-sensitive calcium stores. Nature (1991) 2.16
Use of lipid composition and metabolism to examine structure and activity of estuarine detrital microflora. Appl Environ Microbiol (1977) 2.12
Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure (1996) 2.07
New markers and map sequences in Neurospora crassa, with a description of mapping by duplication coverage, and of multiple translocation stocks for testing linkage. Genetica (1969) 1.97
A non-capacitative pathway activated by arachidonic acid is the major Ca2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J Physiol (1999) 1.94
Isolation and characterization of protein A24, a "histone-like" non-histone chromosomal protein. J Biol Chem (1975) 1.91
T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum (2002) 1.88
Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents. Clin Cancer Res (2000) 1.81
Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer (1999) 1.79
On the coordination of two-handed movements. J Exp Psychol Hum Percept Perform (1979) 1.79
Evidence suggesting that a novel guanine nucleotide regulatory protein couples receptors to phospholipase C in exocrine pancreas. Biochem J (1986) 1.74
An improved method of counting radioactive acrylamide gels. Anal Biochem (1971) 1.70
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst (1995) 1.67
Cooperative activation of IP3 receptors by sequential binding of IP3 and Ca2+ safeguards against spontaneous activity. Curr Biol (1997) 1.63
Binding of catecholamines to connective tissue and the effect upon the responses of blood vessels to noradrenaline and to nerve stimulation. J Physiol (1973) 1.63
Converging evidence for the under-reporting of concussions in youth ice hockey. Br J Sports Med (2006) 1.62
Effects of Ca2+ chelators on purified inositol 1,4,5-trisphosphate (InsP3) receptors and InsP3-stimulated Ca2+ mobilization. J Biol Chem (1993) 1.59
Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology (1993) 1.58
Luminal Ca2+ increases the sensitivity of Ca2+ stores to inositol 1,4,5-trisphosphate. Mol Pharmacol (1992) 1.56
A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci U S A (2000) 1.55
Development and standardization of a rapid, PCR-based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of bancroftian filariasis. Ann Trop Med Parasitol (2002) 1.53
Cloning and sequencing of a human thioredoxin reductase. FEBS Lett (1995) 1.50
Electrophysiological evidence for the cumulative effects of concussion. Brain Inj (2000) 1.50
Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. J Immunol (1988) 1.49
Differential regulation of types-1 and -3 inositol trisphosphate receptors by cytosolic Ca2+. Biochem J (1997) 1.49
Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc (1988) 1.49
All-or-nothing Ca2+ mobilization from the intracellular stores of single histamine-stimulated HeLa cells. J Physiol (1992) 1.49
Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer (1990) 1.48
The management of dysplasia, carcinoma in situ and microcarcinoma of the cervix. J Obstet Gynaecol Br Commonw (1973) 1.48
Two calcium-binding sites mediate the interconversion of liver inositol 1,4,5-trisphosphate receptors between three conformational states. Biochem J (1994) 1.47
Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res (1997) 1.47
Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin Cancer Res (2001) 1.46
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord (1999) 1.45
Vasopressin stimulation of Ca2+ mobilization, two bivalent cation entry pathways and Ca2+ efflux in A7r5 rat smooth muscle cells. J Physiol (1995) 1.45
The thiol reagent, thimerosal, evokes Ca2+ spikes in HeLa cells by sensitizing the inositol 1,4,5-trisphosphate receptor. J Biol Chem (1992) 1.44
Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc (1988) 1.43
Quantal Ca2+ mobilization stimulated by inositol 1,4,5-trisphosphate in permeabilized hepatocytes. Biochem J (1991) 1.42
Calcium and inositol trisphosphate receptors. J Membr Biol (1995) 1.41
Lateral inhibition of inositol 1,4,5-trisphosphate receptors by cytosolic Ca(2+). Curr Biol (1999) 1.39
3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J Med Chem (2000) 1.38
Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem Pharmacol (1999) 1.38
L-Asparaginase production by the rumen anaerobe Vibrio succinogenes. Appl Microbiol (1974) 1.36
Luminal Ca2+ promoting spontaneous Ca2+ release from inositol trisphosphate-sensitive stores in rat hepatocytes. J Physiol (1992) 1.35
Plasma concentration of fentanyl, with 70% nitrous oxide, to prevent movement at skin incision. Anesthesiology (1993) 1.34
On the nature of human interlimb coordination. Science (1979) 1.33
Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin. J Biol Chem (1994) 1.33
Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration (1986) 1.31
Regulation of human thioredoxin reductase expression and activity by 3'-untranslated region selenocysteine insertion sequence and mRNA instability elements. J Biol Chem (1999) 1.30
Purification and characterization of L-asparaginase with anti-lymphoma activity from Vibrio succinogenes. J Biol Chem (1976) 1.28
Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis (1990) 1.28
Liver inositol, 1,4,5-trisphosphate-binding sites are the Ca2(+)-mobilizing receptors. Biochem J (1990) 1.26
Bioaccumulation of 4-nonylphenol in marine animals--a re-evaluation. Environ Pollut (1990) 1.26
Acute idiopathic blind spot enlargement. A big blind spot syndrome without optic disc edema. Arch Ophthalmol (1988) 1.24
Spontaneous Ca2+ spiking in a vascular smooth muscle cell line is independent of the release of intracellular Ca2+ stores. J Biol Chem (1993) 1.24
Two-dimensional electrophoresis of proteins of citric acid nuclei prepared with aid of a Tissumizer. Exp Cell Res (1973) 1.23
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro. J Natl Cancer Inst (1992) 1.23
Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. Clin Cancer Res (2001) 1.22
Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides. Biochem Pharmacol (1998) 1.22
Biphasic effects of cytosolic Ca2+ on Ins(1,4,5)P3-stimulated Ca2+ mobilization in hepatocytes. J Biol Chem (1993) 1.22
Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors. Mol Pharmacol (1994) 1.21
Structural analysis of the glycine-rich, arginine-rich histone. 3. Sequence of the amino-terminal half of the molecule containing the modified lysine residues and the total sequence. J Biol Chem (1969) 1.21
Relationship of the single-electron reduction potential of quinones to their reduction by flavoproteins. Biochem Pharmacol (1980) 1.20
In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin. Anticancer Res (1995) 1.20
Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization. Proc Natl Acad Sci U S A (1997) 1.20
Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum Pathol (2000) 1.20
Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol (1997) 1.20
Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol (1994) 1.18
Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res (1997) 1.17
The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology (1994) 1.16
Genetic and molecular characterization of suppressors of SIR4 mutations in Saccharomyces cerevisiae. Genetics (1989) 1.15
A novel role for calmodulin: Ca2+-independent inhibition of type-1 inositol trisphosphate receptors. Biochem J (1998) 1.15
Rapid activation and partial inactivation of inositol trisphosphate receptors by inositol trisphosphate. Biochemistry (1998) 1.14
Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ (1995) 1.13
Factors contributing to helical shape determination and maintenance in Bacillus subtilis macrofibres. Ann Inst Pasteur Microbiol (1985) 1.13
The B lymphocyte calcium response to anti-Ig is diminished by membrane immunoglobulin cross-linkage to the Fc gamma receptor. J Immunol (1987) 1.13